Indeed, plasma levels of IFN-ɣ-inducible chemokines CXCL9 and CXCL10 have been correlated with survival and chemotherapeutic efficacy in advanced ductal adenocarcinoma [44]. This evidence concerns the gene CXCL10 and invasive ductal breast carcinoma.